SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicenne Reports MDNA209 Preclinical Autoimmune Disease Findings

Medicenne reported CD122 blockade and extended survival with MDNA209 in preclinical models of autoimmune disease.

Related stories